SEC Filings

424B5
GLOBAL BLOOD THERAPEUTICS, INC. filed this Form 424B5 on 12/06/2018
Entire Document
 


Table of Contents

PRICE RANGE OF COMMON STOCK

Our common stock began trading on The Nasdaq Global Select Market under the symbol “GBT” on August 12, 2015. Prior to that time, there was no public market for our common stock. The following table sets forth the high and low sale prices per share of our common stock, as reported on The Nasdaq Global Select Market, for the periods indicated:

 

     High      Low  

Year ended December 31, 2015

     

Third quarter (from August 12, 2015)

   $ 57.00      $ 33.01  

Fourth quarter

   $ 55.74      $ 28.73  

Year ended December 31, 2016

     

First quarter

   $ 31.97      $ 12.24  

Second quarter

   $ 27.99      $ 14.22  

Third quarter

   $ 24.10      $ 16.07  

Fourth quarter

   $ 23.80      $ 13.35  

Year ended December 31, 2017

     

First quarter

   $ 41.15      $ 14.00  

Second quarter

   $ 37.50      $ 25.65  

Third quarter

   $ 31.30      $ 24.03  

Fourth quarter

   $ 45.85      $ 29.45  

Year ending December 31, 2018

     

First quarter

   $ 68.05      $ 38.80  

Second quarter

   $ 51.65      $ 33.80  

Third quarter

   $ 52.65      $ 37.75  

Fourth quarter (through December 4, 2018)

   $ 50.11      $ 30.15  

On December 4, 2018, the last reported sale price of our common stock as reported on The Nasdaq Global Select Market was $45.45 per share. As of December 4, 2018, there were approximately 11 record holders of our common stock. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.

The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company. The transfer agent’s address is 1 State Street, 30th Floor, New York, NY 10004-1561 and its telephone number is (212) 509-4000.

 

S-16